OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

CFO exercised or converted 9,388 HIMS derivative securities | OQRO

Home
Insider trades
Hims & Hers Health
CFO exercised or converted 9,388 HIMS derivative securities

Insider trades

Insider trade

CFO exercised or converted 9,388 HIMS derivative securities

Traded Aug 17, 2026 · Filed Aug 18, 2026

HIMHims & Hers HealthHIMS

9,388
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 17, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 18, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001773751-26-000210

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Aug 18, 2026, 9:04 PM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Hims & Hers Health, Inc.

Issuer CIK

1773751

Ticker

HIMS

Reporting person

Oluyemi Okupe

Relationship

Officer

Officer title

Chief Financial Officer

Security

Stock Option (right to buy)

Table

Derivative (Table II)

Transaction date

Aug 17, 2026

Transaction code

Shares / units

9,388

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

85,810

Ownership form

Direct

Amendment

Footnotes from the filing

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
This stock option award is fully vested.

Around the same time

Soleil Boughton (Chief Legal Officer) sold ~$174K of Hims & Hers Health

Scheduled in advanceFiled 3w ago

Michael Chi (Chief Operating Officer) sold ~$398K of Hims & Hers Health

Scheduled in advanceFiled 3w ago

Mohamed Elshenawy (CTO) sold ~$226K of Hims & Hers Health

Scheduled in advanceFiled 3w ago